Epigenome editing therapeutics for chronic diseases
At a glance
- HQ: Durham
- Sector: Biotech
- Stage: Series B
- Total raised: $215M
- Last round: Series B
The rest of this record is behind a free account.
Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately, and I read every signup.